Literature DB >> 16905787

Biology of CCR5 and its role in HIV infection and treatment.

Michael M Lederman1, Adam Penn-Nicholson, Michael Cho, Donald Mosier.   

Abstract

Chemokine receptors are found on cell surfaces and promote cellular migration by chemotaxis. The CC chemokine receptor 5 (CCR5) is used by the human immunodeficiency virus (HIV) to infect cells. Strategies that target human CCR5 are therefore being developed to prevent and treat HIV infection. Antiviral strategies that target a host element necessary for viral replication may be predicted to interfere with the function of that element and may therefore adversely affect the host. We conducted a review of the literature between November 2005 and April 2006 with a focus on articles addressing the genetics and function of CCR5, the effects of CCR5 deletion in human and murine systems, and treatment strategies for HIV infection that target this coreceptor. English-language articles in the human and murine literature published between March 1996 and April 2006 were identified through a search of MEDLINE using CCR5 as the search term. Relevant articles as judged by their titles and abstracts were reviewed in detail. In addition, based on our knowledge of the field and with permission, unpublished work was also reviewed. In this article, we explore the effects that targeting CCR5 may have on host defenses in individuals with immunity already compromised by HIV infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16905787     DOI: 10.1001/jama.296.7.815

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  83 in total

1.  Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy.

Authors:  Binshan Shi; Christina Kitchen; Barbara Weiser; Douglas Mayers; Brian Foley; Kimdar Kemal; Kathryn Anastos; Marc Suchard; Monica Parker; Cheryl Brunner; Harold Burger
Journal:  Virology       Date:  2010-05-08       Impact factor: 3.616

2.  CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques.

Authors:  Jessica E Taaffe; Steven E Bosinger; Gregory Q Del Prete; James G Else; Sarah Ratcliffe; Christopher D Ward; Thi Migone; Mirko Paiardini; Guido Silvestri
Journal:  J Med Primatol       Date:  2011-11-14       Impact factor: 0.667

3.  Phase 2a study of the CCR5 monoclonal antibody PRO 140 administered intravenously to HIV-infected adults.

Authors:  Jeffrey M Jacobson; Jacob P Lalezari; Melanie A Thompson; Carl J Fichtenbaum; Michael S Saag; Barry S Zingman; Paul D'Ambrosio; Nancy Stambler; Yakov Rotshteyn; Andre J Marozsan; Paul J Maddon; Stephen A Morris; William C Olson
Journal:  Antimicrob Agents Chemother       Date:  2010-07-26       Impact factor: 5.191

Review 4.  Th17 cell dynamics in HIV infection.

Authors:  Nichole R Klatt; Jason M Brenchley
Journal:  Curr Opin HIV AIDS       Date:  2010-03       Impact factor: 4.283

5.  Circulating human CD4 and CD8 T cells do not have large intracellular pools of CCR5.

Authors:  Heather A Pilch-Cooper; Scott F Sieg; Thomas J Hope; Ann Koons; Jean-Michel Escola; Robin Offord; Ronald S Veazey; Donald E Mosier; Brian Clagett; Kathy Medvik; Julie K Jadlowsky; Mark R Chance; Janna G Kiselar; James A Hoxie; Ronald G Collman; Nadeene E Riddick; Valentina Mercanti; Oliver Hartley; Michael M Lederman
Journal:  Blood       Date:  2010-11-10       Impact factor: 22.113

6.  Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity.

Authors:  Paolo Lusso; Luca Vangelista; Raffaello Cimbro; Massimiliano Secchi; Francesca Sironi; Renato Longhi; Marina Faiella; Ornella Maglio; Vincenzo Pavone
Journal:  FASEB J       Date:  2011-01-03       Impact factor: 5.191

Review 7.  Forward genetic dissection of innate response to infection in inbred mouse strains: selected success stories.

Authors:  S Gruenheid; P Gros
Journal:  Clin Exp Immunol       Date:  2010-12       Impact factor: 4.330

8.  Ccr5 regulates inflammatory gene expression in response to encephalomyocarditis virus infection.

Authors:  Benjamin S Christmann; Jason M Moran; Jennifer A McGraw; R Mark L Buller; John A Corbett
Journal:  Am J Pathol       Date:  2011-10-11       Impact factor: 4.307

9.  Specificity for a CCR5 Inhibitor Is Conferred by a Single Amino Acid Residue: ROLE OF ILE198.

Authors:  Gloria Lau; Jean Labrecque; Markus Metz; Roy Vaz; Simon P Fricker
Journal:  J Biol Chem       Date:  2015-03-12       Impact factor: 5.157

10.  The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial.

Authors:  Peter W Hunt; Nancy S Shulman; Timothy L Hayes; Viktor Dahl; Ma Somsouk; Nicholas T Funderburg; Bridget McLaughlin; Alan L Landay; Oluwatoyin Adeyemi; Lee E Gilman; Brian Clagett; Benigno Rodriguez; Jeffrey N Martin; Timothy W Schacker; Barbara L Shacklett; Sarah Palmer; Michael M Lederman; Steven G Deeks
Journal:  Blood       Date:  2013-04-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.